Approval for early termination of enrollment for the post-approval study (pas) referenced above. The pas protocol has been submitted to comply with the conditions of approval outlined in our approval order for p150039.
Device | Tryton Side Branch Stent |
Generic Name | Stent, Coronary |
Applicant | Poseidon Medical Inc. |
Date Received | 2020-09-04 |
Decision Date | 2020-10-04 |
PMA | P150039 |
Supplement | S005 |
Product Code | MAF |
Advisory Committee | Cardiovascular |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Postapproval Study Protocol - Ode/oir |
Expedited Review | No |
Combination Product | No |
Applicant Address | Poseidon Medical Inc. 1125 Nw 132nd Avenue pembroke Pines, FL 33028 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P150039 | | Original Filing |
S005 |
2020-09-04 |
Normal 180 Day Track No User Fee |
S004 |
2019-06-07 |
30-day Notice |
S003 |
2017-09-29 |
Normal 180 Day Track No User Fee |
S002 |
2017-07-11 |
30-day Notice |
S001 |
2017-03-13 |
Normal 180 Day Track No User Fee |
NIH GUDID Devices